NHIA to assess paying hefty price for new hemophilia B gene therapy

Taipei, Aug. 19 (CNA) The National Health Insurance Administration (NHIA) will evaluate including a one-time gene therapy to treat individuals with hemophilia B in the NHI drug reimbursement scheme after it is approved in Taiwan, an NHIA official said Monday.

NHIA to assess paying hefty price for new hemophilia B gene therapy

NHIA to assess paying hefty price for new hemophilia B gene therapy

NHIA to assess paying hefty price for new hemophilia B gene therapy

NHIA to assess paying hefty price for new hemophilia B gene therapy
NHIA to assess paying hefty price for new hemophilia B gene therapy
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Boxer Carini to get award despite loss to Khelif
Typhoon Gaemi displaces nearly 300,000 in eastern China

Boxer files legal complaint over gender abuse
Dwight Howard: 'I Was Depressed Like Hell. I Know I'm Supposed to Be Playing in' NBA